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Cutaneous apocrine carcinoma (AC) is a rare adnexal neoplasm that histologically can mimic breast carcinoma
metastatic to the skin or apocrine carcinoma arising in ectopic breast tissue. As extremely rare condition,
neuroendocrine differentiation may be observed in AC although its etiology and pathogenesis is still unclear. We
report here a case of unusual AC with neuroendocrine differentiation in right labium majus pudenda. A 43-year-old
woman presented with a 6-month history of an asymptomatic pea-sized brownish nodule in right labium majus
pudenda without enlargement of inguinal lymph nodes and bilateral breast nodules. The mass was totally resected.
Microscopically, the tumor was solitary and located in the deep dermis without epidermal connection. Tumor cells
were arranged in a micronodular or formed massive solid nests separated by densely fibroblastic stroma. Scattered
glandular or rosette-like structures were identified within the tumor nodules. Immunohistochemically, the tumor
cells were diffusely positive to CK7, CEA, GCDFP-15, synaptophysin, estrogen and progesterone receptors. Part of
tumor cells expressed androgen receptor, but they were negative to CK20, CK5/6, p63 and S-100. Because of its
rarity and histogenesis complexity, there exist diagnostic challenges for pathologists to differentiate cutaneous AC
with neuroendocrine differentiation from other carcinomas with apocrine or neuroendocrine features. Our case
demonstrates that the tumor shares some features with mammary carcinoma and might originate from mammary-like
sweat gland in anogenital region. The results suggest that, for the first time, primary cutaneous AC with
neuroendocrine differentiation may be analogous to the mammary neuroendocrine carcinoma with apocrine
differentiation in histological feature and biological behavior.
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Apocrine carcinoma (AC) is a rare malignant sweat
gland neoplasm with apocrine differentiation. It often
affects the skin and subcutaneous tissues in axilla and
anogenital region of adults without gender bias and racial
predilection [1]. In 2006, World Health Organization
(WHO) classification of skin tumors have accepted AC as
a separate entity, and identified it as a slow growing tumor
with a tendency toward a prolonged course, although
reliable predictive factors of this tumor have not been
established because reports of this tumor are rare and
sporadic [2]. In exceedingly rare condition, AC can immu-
nohistochemically and electron microscopically exhibit
neuroendocrine differentiation. To the best of our know-
ledge, only 1 case of AC with neuroendocrine differenti-
ation has been reported in the literature [3]. However,
there is no report after this tumor has been established as
a distinct entity. Herein, we present an unusual AC with
neuroendocrine differentiation occurring in labium majus
pudenda of a middle-aged female patient. The clinical and
histological features of this tumor, as well as differential
diagnosis are discussed.
Case presentation
Clinical manifestation and management
A 43-year-old woman presented with an asymptomatic
pea-sized brownish nodule in right labium majus pudenda
for 6 months. She had no remarkable medical or family
history. Clinical examination revealed a dome-shaped elas-
tic nodule, measuring 0.5 cm in diameter in right labium
majus pudenda. No cutaneous ulceration was found, and
no lymph node was palpable in the bilateral inguinal areas.
There was no mass lesion was palpated in the bilateral
breast. Routine laboratory test results provided no positive
finding, suggesting no bodily biochemical abnormality.
The mass excision was performed under the impression of
an epidermal cyst or skin fibroma. Intraoperative finding
revealed that the mass had no fibrous capsule and located
in the deeper dermis. The mass was found to adhere to
the underlying tissue, and the border between the mass
and subcutaneous fatty tissue was indistinct. However, the
mass was not observed to invade the epidermis. The mass
was totally removed.
Pathological findings
The surgical specimen was received and routinely fixed
in 10 % neutral buffered formalin after tumor resection.
Four micrometer thick sections were cut and stained
with H&E. Microscopic examination revealed the tumor
was solitary and located in the deep dermis without epi-
dermal connection. The mass had an infiltrating border,
and tumor cells were observed to spread into the sub-
cutaneous fatty tissue with neural invasion. The tumor
was composed of two types of cells. One was round topolygonal cells, which had eosinophilic, relatively narrow
cytoplasm. The other had abundant pale or foamy cyto-
plasm. Both two types of tumor cell had enlarged nuclei
with distinct nucleoli. These tumor cells were arranged
in a micronodular or formed massive solid nests sepa-
rated by densely fibroblastic stroma. However, scattered
glandular or rosette-like structures representing ductal
lumina were identified within the tumor nodules. There
was no bluish mucinous material observed in the duct
lumina. Both tumor cells showed mild to moderate atypia
with low mitotic activity (1/10 high power fields). Neither
tumor necrosis nor hemorrhage was noted in the tumor
(Fig. 1). Immunohistochemically, the tumor cells were dif-
fusely immuno-positive to pan-cytokeratin (Pan-CK), CK7,
epithelial membrane antigen (EMA), carcinoembryonic
antigen (CEA), gross cystic disease fluid protein (GCDFP)-
15. More than 80 % of the tumor cells were also reactive
to estrogen receptors (ER) and progesterone receptors
(PR), synaptophysin and chromogranin A. About 50 % of
tumor cells were detected to be positive to androgen
receptors (AR), but both two types of tumor cell did not
express CK20, mammaglobin and myoepithelial cells
markers, such as CK5/6, S-100 protein and p63 (Fig. 2).
Alcian blue staining showed there was no intra-cytoplas-
mic or intra-glandular mucin production in the tumor.
On the basis of gross, histopathological features and
immunohistochemical phenotypes, its dermal location,
the presence of infiltrating growth pattern and neural
invasion, a diagnosis of cutaneous apocrine carcinoma
with neuroendocrine differentiation was made. Since
there was a possibility of skin metastatic carcinoma from
apocrine mammary carcinoma, the patient was referred
to a whole body positron emission tomography (PET)/
CT study to search for the potentially breast tumor, but
no abnormality was found. Because the margin of the
tumor was ill-defined, the second excision with a wide
margin (1 mm to the excision margin) was performed
after diagnosis. The section margin was free. The postop-
erative phase was uneventful, and no additional treatments
were undertaken. The patient was on regular follow-up for
12 months after discharging from hospital. There was no
sign of tumor recurrence and lymph node enlargement.
Discussion
Cutaneous apocrine carcinoma (AC) is a rare adnexal
neoplasm that histologically can mimic breast carcinoma
metastatic to the skin or apocrine carcinoma arising in ec-
topic breast tissue. Most cutaneous AC arises in the axilla
or anogenital region. But rare locations, such as the scalp,
face, and extremities have also been described [4, 5]. It can
present with a wide range of clinical modalities and fre-
quently occur in the adults with an average age of
57.9 years [6]. In many cases, the lesions have been stand-
ing for more than 10 years, and even up to 30 years before
Fig. 1 Micrographs of cutaneous mass in postoperative histological examination. a A solitary well-circumscribed mass was found in the deep
dermis without epidermal connection. The tumor cells formed nodule or solid nests separated by densely fibroblastic stroma. b Higher magnification
showed the two types of tumor cell mixed in the solid nest. c Under the high power field, one type of tumor cell was round to polygonal cells, which
had eosinophilic, relatively narrow cytoplasm. The other had abundant pale or foamy cytoplasm. Both two types of tumor cell had enlarged nuclei
with distinct nucleoli. d The tumor cells showed mild to moderate atypia with scattered mitotic figures (black arrow). e There were scattered glandular
or rosette-like structures identified within the tumor nodules (black arrow). f The tumor cells were observed to spread into the subcutaneous
fatty tissue with neural invasion. a, H&E staining with original magnification × 100; b-f, H&E staining with original magnification × 400)
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that all patients were over 25 years suggests that full
maturity of the apocrine gland is a prerequisite. Although
AC is thought to arise from apocrine gland, an interesting
alternative origin is the newly described mammary-like
sweat gland of the anogenital region [7]. In the present
case, the tumor locates in the deep dermis of anogenital
region, whether or not it derives from mammary-like
sweat gland should be clarified further.
Despite its enigmatic histogenesis, AC with neuroen-
docrine differentiation is extremely rare. To the best of
our knowledge, only 1 case have been reported in theliterature, and there is no report after this tumor is
established as a distinct entity in 2006 [3]. In that case, a
solitary tumor was found in the pubic area. The tumor
was composed of polygonal atypical cells in a cord- or
ribbon-like fashion. Like our presenting case, the tumor
cells stained positive to CEA, GCDFP-15, CK7, chromogra-
nin A, progesterone and androgen receptors. Membrane-
bound dense core granules, representing neurosecretory
granules, were ultrastructually found in some of the cells.
The author suggests that AC with neuroendocrine
differentiation shares several features with mammary
carcinoma [3].
Fig. 2 Immunohistochemical features of cutaneous mass. Immunohistochemically, the tumor cells were diffusely immuno-positive to CK7 a, CEA
b, Synaptophysin c, GCDFP-15 d, and estrogen receptor e. f About 50 % of tumor cells were detected to be positive to androgen receptor (AR).
(a-f, immunohistochemical staining with original magnification × 400)
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ily on the axilla and in the anogenital region. However,
modified apocrine glands exist in the eyelid (Moll’s
gland), in the ear canal (ceruminous glands), and in the
breast as mammary glands [8]. Several tumors with
identical morphologies can occur in these organs. For
example, endocrine mucin-producing sweat gland car-
cinoma is analogous to the mammary solid-papillary car-
cinoma histopathologically and immunohistochemically
[9, 10]. Whether or not primary cutaneous AC with neu-
roendocrine differentiation has also an analogous lesion
in breast? To our knowledge, there are two histotypes of
breast cancer exhibit apocrine morphological and immu-
nohistochemical features. They are carcinoma with apo-
crine differentiation and neuroendocrine carcinoma withapocrine differentiation. Mammary carcinoma with apo-
crine differentiation is composed of type A and type B
cells with typically GCDFP15 and androgen receptor
positive, estrogen and progesterone receptors negative
[11]. The presence of cells with co-expression of apo-
crine and neuroendocrine markers has never been de-
scribed in this specific subtype of breast cancer. In our
case, two cell types with distinct morphological features
are similar to the type A and B cells identified in the car-
cinoma with apocrine differentiation. However, we ruled
out this diagnosis on the basis of the positive expression
to estrogen and progesterone receptors, as well as syn-
chronic neuroendocrine markers expression.
Neuroendocrine carcinoma with apocrine differentiation
is a rare variant of breast neuroendocrine carcinoma with
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been described in the most recent WHO’s classification of
tumor of breast [14]. Few case reports of breast neuroen-
docrine carcinoma with apocrine differentiation have
demonstrated that this tumor is closely associated with
strong expression of estrogen, progesterone and androgen
receptors [12, 13, 15]. However, only approximately 60 %
cases of primary cutaneous AC showed ER and PR posi-
tive in tumor cells. [16]. In present case, we found some
analogous features between AC with neuroendocrine dif-
ferentiation and mammary neuroendocrine carcinoma
with apocrine differentiation. Morphologically, both tu-
mors are composed of multiple circumscribed cellular and
solid nodules separated by densely fibroblastic stroma.
Each nodule comprises polygonal to ovoid cells with
abundant eosinophilic granular cytoplasm forming focal
rosette-like structures or small ductal lumina. Immunohis-
tochemically, both tumors co-express neuroendocrine and
apocrine markers diffusely. More importantly, similar to
neuroendocrine carcinoma with apocrine differentiation,
AC with neuroendocrine differentiation also expresses es-
trogen and progesterone receptors. These similar features
might imply the correlation between these two distinct tu-
mors. In agreement with previous studies, our result sup-
ports the hypothesis of the AC having originated from
mammary-like sweat gland of the anogenital region. We
presume that primary cutaneous AC with neuroendocrine
differentiation, similar to its mammary counterpart, neu-
roendocrine carcinoma with apocrine differentiation,
could present analogous characteristics in histomorphol-
ogy and biological behavior.
Because of histological resemblance, many authors
consider that ACs located in axillary region is indistin-
guishable from metastatic breast adenocarcinoma
[17–19], and that a detailed clinical pathological correl-
ation needs to be established to distinguish between
them [2, 20]. As for cutaneous AC with neuroendocrine
differentiation, it could be distinguished from metastatic
breast carcinoma with apocrine differentiation by the
presence of co-expression of apocrine and neuroendo-
crine markers in tumor cells, and the absence of primary
carcinoma in bilateral breast. However, it might be indis-
tinguishable from neuroendocrine carcinoma with apo-
crine differentiation of ectopic breast tissue in axillary or
anogenital region. Since the AC in the anogenital region
might arise from mammary-like sweat gland, in fact, we
have no idea to confirm if our case is indeed a neuroen-
docrine carcinoma with apocrine differentiation of ec-
topic breast tissue in anogenital region even if there is
absence of ectopic mammary tissue in the sample. The
morphological features and immunohistochemical stain-
ing are non-specific for their differentiation. The accur-
ate cliniopathological criteria need to be established
further.There are no standardized protocols for the treatment
of AC. Wide local excision with margins between 1 and
2 mm has been recommended. The previously reported
case of AC with neuroendocrine differentiation exhibited
a poor prognosis, the patient died of regional lymph
node metastasis and multiple pulmonary metastasis
22 months after surgical excision [3]. However, several
cases of breast neuroendocrine carcinoma indicated that
the association with apocrine differentiation seemed to
improve long-term survival of patients with neuroendo-
crine carcinoma [12, 15]. Regardless of its ectopic breast
origin, in case cutaneous AC with neuroendocrine differ-
entiation is analogous to the mammary neuroendocrine
carcinoma with apocrine differentiation, we postulate a
favorable prognosis in our case. Of course, a longer
period of follow-up is necessary to be performed to
supervise the tumor progression.
Conclusion
Because of its rarity and histogenesis complexity, there
exist diagnostic challenges for pathologists to differentiate
cutaneous AC with neuroendocrine differentiation from
other carcinomas with apocrine or neuroendocrine fea-
tures, especially when the tumor occurs in axillary and
anogenital region. It is important to be able recognize this
tumor in order to avoid potential misdiagnosis and im-
proper management of afflicted patients. This tumor
shares some features with mammary carcinoma and might
originate from mammary-like sweat gland. Our results
suggest that, for the first time, primary cutaneous AC with
neuroendocrine differentiation may be analogous to the
mammary neuroendocrine carcinoma with apocrine dif-
ferentiation in histological feature and biological behavior.
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